Shares of Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTX – Get Free Report) traded down 3.9% on Tuesday . The company traded as low as $0.03 and last traded at $0.71. 5,696 shares traded hands during trading, an increase of 171% from the average session volume of 2,099 shares. The stock had previously closed at $0.74.
Fresh Tracks Therapeutics Price Performance
The company has a 50-day simple moving average of $0.73 and a 200-day simple moving average of $0.79. The stock has a market cap of $4.25 million, a PE ratio of -0.50 and a beta of 0.51.
Fresh Tracks Therapeutics Company Profile
Fresh Tracks Therapeutics, Inc does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc was founded in 2009 and is headquartered in Boulder, Colorado.
Further Reading
- Five stocks we like better than Fresh Tracks Therapeutics
- Golden Cross Stocks: Pattern, Examples and Charts
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- The Most Important Warren Buffett Stock for Investors: His Own
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- What to Know About Investing in Penny Stocks
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Fresh Tracks Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh Tracks Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
